Study identifier:NXL104-1004

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Start Date: -

Primary Completion Date: -

Study Completion Date: -

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verified 01 May 2015 by AstraZeneca

Inclusion and exclusion criteria

Sort by status

No locations available

Arms	Assigned Interventions

Documents available